Quarterly report · Q2
4188.TEDINET S100PK3O
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.27T | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥1.16T | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥3.98T | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥1.89T | 2021-04-01 → 2021-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥956.8bn | 2021-07-01 → 2021-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥118.4bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥50.3bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥153.1bn | 2021-04-01 → 2021-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥66.1bn | 2021-07-01 → 2021-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥122.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥46.9bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥290.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥147.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.9bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥73.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥29.1bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥177.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥85.2bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥35.2bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥91.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥38.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥209.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥101.9bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥42.7bn | 2021-07-01 → 2021-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.00T | at 2022-09-30 | Cons. | Assets IFRS |
| Total assets | ¥5.57T | at 2022-03-31 | Cons. | Assets IFRS |
| Total assets | ¥5.32T | at 2021-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.96T | at 2022-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.73T | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.04T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.84T | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.67T | at 2021-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.57T | at 2021-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.63T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.46T | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.32T | at 2021-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥253.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥257.7bn | at 2021-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥349.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥93.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥346.9bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥166.3bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥117.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥128.8bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥107.5bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥15.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥336.3bn | 2021-04-01 → 2022-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥151.4bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥52.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥20.44 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥124.68 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥59.94 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥24.8 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥49.79 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.58 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥115.03 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥55.13 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥22.82 | 2021-07-01 → 2021-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 27.1% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 26.2% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 24.8% | at 2021-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥205.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥108.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥96.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥6.6bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥152.9bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥6.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥771.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥745.4bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥26.0bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥22.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥212.3bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥212.0bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥309m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥573.7bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥569.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥54.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥659.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥634.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥25.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥42.3bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.22T |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.16T |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥56.1bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥122.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥2.42T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥2.27T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥152.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥129.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2021-09-30 | ¥172.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2021-09-30 | ¥81.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥90.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-09-30 | ¥6.1bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥140.6bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥7.3bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥614.8bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥593.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥20.9bn |
| jpcrp040300-q2r_E00808-000Chemicalsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥62.2bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥198.7bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥198.5bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥171m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥447.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥444.1bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥48.3bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥592.2bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥566.7bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥25.5bn |
| jpcrp040300-q2r_E00808-000Performance Productsreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥45.8bn |
| —segment total | revenue | 2021-04-01 → 2021-09-30 | ¥1.85T |
| —segment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.80T |
| —segment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥49.8bn |
| —segment total | segment profit | 2021-04-01 → 2021-09-30 | ¥157.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥2.03T |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥1.89T |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥140.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥163.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 950
| Item | Context | Value | Unit |
|---|---|---|---|
| Fund code | FilingDateInstant | - | |
| Security code | FilingDateInstant | 41880 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)三菱ケミカルグループ株式会社 | |
| Filer name in english | FilingDateInstant | Mitsubishi Chemical Group Corporation | |
| Fund name in japanese | FilingDateInstant | - | |
| Fund name in english | FilingDateInstant | - | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | IFRS | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | - | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-09-30 | |
| Type of current period | FilingDateInstant | Q2 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-09-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | - | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | - | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | - | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数は100株です。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)日本マスタートラスト信託銀行 株式会社信託口 | |
| Address major shareholders | CurrentQuarterInstant_No1MajorShareholdersMember | Original text (Japanese)東京都港区浜松町2-11-3 | |
| Name major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)SSBTC CLIENT OMNIBUS ACCOUNT(常任代理人) 香港上海銀行東京支店カストディ業務部 | |
| Address major shareholders | CurrentQuarterInstant_No2MajorShareholdersMember | Original text (Japanese)ONE LINCOLN STREET, BOSTON MA USA 02111(東京都中央区日本橋3-11-1) | |
| Name major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)株式会社日本カストディ銀行 信託口 | |
| Address major shareholders | CurrentQuarterInstant_No3MajorShareholdersMember | Original text (Japanese)東京都中央区晴海1-8-12 | |
| Name major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)明治安田生命保険相互会社(常任代理人)株式会社日本カストディ銀行 | |
| Address major shareholders | CurrentQuarterInstant_No4MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内2-1-1(東京都中央区晴海1-8-12) | |
| Name major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)日本生命保険相互会社(常任代理人)日本マスタートラスト信託銀行株式会社 | |
| Address major shareholders | CurrentQuarterInstant_No5MajorShareholdersMember | Original text (Japanese)東京都千代田区丸の内1-6-6(東京都港区浜松町2-11-3) |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |